PH12014501772A1 - Rapidly disintegrating tablet - Google Patents

Rapidly disintegrating tablet

Info

Publication number
PH12014501772A1
PH12014501772A1 PH12014501772A PH12014501772A PH12014501772A1 PH 12014501772 A1 PH12014501772 A1 PH 12014501772A1 PH 12014501772 A PH12014501772 A PH 12014501772A PH 12014501772 A PH12014501772 A PH 12014501772A PH 12014501772 A1 PH12014501772 A1 PH 12014501772A1
Authority
PH
Philippines
Prior art keywords
disintegrating tablet
carbon dioxide
rapidly disintegrating
drug
function
Prior art date
Application number
PH12014501772A
Other versions
PH12014501772B1 (en
Inventor
Ito Yoshitaka
Maeda Atsushi
Kashihara Sumie
Otake Katsuto
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of PH12014501772B1 publication Critical patent/PH12014501772B1/en
Publication of PH12014501772A1 publication Critical patent/PH12014501772A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Abstract

Provided are: a rapidly disintegrating tablet (in particular, an orally disintegrating tablet) containing drug-containing particles imparting a desired function based on the properties of the drug, which tablet still fully expresses the function even after a formulation step which might sometimes have an impact on the function thereof; and a method for producing the same. The rapidly disintegrating tablet is obtained by treating, with carbon dioxide in a super critical or subcritical state or with carbon dioxide liquid or gas, a drug and a material which is given the function of a binding agent by treatment with carbon dioxide in a super critical or subcritical state or with carbon dioxide liquid or gas.
PH12014501772A 2012-03-02 2014-08-06 Rapidly disintegrating tablet PH12014501772A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012046501 2012-03-02
JP2012239773 2012-10-31
PCT/JP2013/055634 WO2013129644A1 (en) 2012-03-02 2013-03-01 Rapidly disintegrating tablet

Publications (2)

Publication Number Publication Date
PH12014501772B1 PH12014501772B1 (en) 2014-11-10
PH12014501772A1 true PH12014501772A1 (en) 2014-11-10

Family

ID=49082831

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12014501772A PH12014501772A1 (en) 2012-03-02 2014-08-06 Rapidly disintegrating tablet

Country Status (6)

Country Link
JP (1) JP6098634B2 (en)
KR (1) KR102092423B1 (en)
CN (1) CN104168891B (en)
PH (1) PH12014501772A1 (en)
TW (1) TWI612975B (en)
WO (1) WO2013129644A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015004244A2 (en) * 2012-08-31 2017-07-04 Astellas Pharma Inc orally administered medical composition
EP2848241A1 (en) * 2013-09-12 2015-03-18 Sanovel Ilac Sanayi ve Ticaret A.S. Effervescent formulations of linagliptin
EP2848242A1 (en) * 2013-09-12 2015-03-18 Sanovel Ilac Sanayi ve Ticaret A.S. Orally disintegrating formulations of Linagliptin
CN105194677A (en) * 2014-06-23 2015-12-30 天津金耀集团有限公司 Lactose celecoxib medicine composition
WO2019036483A1 (en) 2017-08-15 2019-02-21 Nephron Pharmaceuticals Corporation Aqueous nebulization composition
JPWO2020213589A1 (en) * 2019-04-15 2020-10-22
CN112979964B (en) * 2021-02-22 2022-05-31 烟台大学 High-toughness shellac and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9603035A (en) 1994-01-31 1997-05-31 Yamanouchi Pharma Co Ltd Intraorally soluble compressed molding and process for producing the same.
JPH1133084A (en) 1994-02-10 1999-02-09 Yamanouchi Pharmaceut Co Ltd Intraoral soluble type tablet and manufacture thereof
JP2919771B2 (en) 1995-04-17 1999-07-19 佐藤製薬株式会社 Method for producing fast-dissolving tablet and fast-dissolving tablet produced by the method
EP1323417B1 (en) 2001-05-10 2006-07-19 Astellas Pharma Inc. Tablets quickly disintegrating in the oral cavity and process for producing the same
MY147403A (en) * 2003-04-29 2012-11-30 Kowa Co Composition containing medicine extremely slightly solube in water and method for preparation thereof
EP1699441B1 (en) * 2003-12-17 2010-05-19 Pantec AG Method of manufacture of fast-disintegrating tablets
JP2006076971A (en) 2004-09-13 2006-03-23 Basf Ag Orally disintegrating tablet
WO2006070845A1 (en) 2004-12-28 2006-07-06 Eisai R & D Management Co., Ltd. Quick disintegration tablet and method of producing the same
KR101075556B1 (en) 2008-11-21 2011-10-20 씨제이제일제당 (주) Orally fast-disintegrating tablets and processes for the preparation thereof

Also Published As

Publication number Publication date
KR20140130736A (en) 2014-11-11
TWI612975B (en) 2018-02-01
JP6098634B2 (en) 2017-03-22
KR102092423B1 (en) 2020-03-23
PH12014501772B1 (en) 2014-11-10
CN104168891B (en) 2016-05-11
TW201350141A (en) 2013-12-16
JPWO2013129644A1 (en) 2015-07-30
WO2013129644A1 (en) 2013-09-06
CN104168891A (en) 2014-11-26

Similar Documents

Publication Publication Date Title
PH12014501772A1 (en) Rapidly disintegrating tablet
EP3156081A4 (en) Cell structure for use in treatment of brain injury, method for producing same, and therapeutic agent for brain injury
WO2014167358A3 (en) Method for treating a substrate made of animal fibers with solid particles and a chemical formulation comprising a colourant
TN2015000050A1 (en) Methods of treating a tauopathy
PH12015500561A1 (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
MX363243B (en) Compositions and methods for treating cancer.
WO2014149477A8 (en) Methods for achieving therapeutically effective doses of anti-cd47 agents
WO2012106356A3 (en) Virus-like particles and methods of use
MY179194A (en) Process for preparing therapeutic nanoparticles
MX2013008850A (en) Compositions and methods for treating cardiovascular diseases.
MX2017007128A (en) Hydraulic fracturing composition, method for making and use of same.
WO2013002479A3 (en) Nanoemulsion composition and method for preparing same
WO2012052873A3 (en) An apparatus for treating a product
WO2013081690A3 (en) Retinal laser surgery
MX363670B (en) Bromocriptine formulations.
EP3147353A4 (en) Method for producing pancreatic blast cells and pancreatic disease treatment agent containing pancreatic blast cells
WO2012126005A3 (en) Polymer hydrogels for in vivo applications and methods for using and preparing same
PH12014502834B1 (en) Pharmaceutical form for extended release of active substances
EP3481536A4 (en) Method and apparatus for recovering absorbing agents in acid gas treatment
WO2014072423A3 (en) Agitation apparatus
WO2010086838A3 (en) Non-ad5 adenoviral vectors and methods and uses related thereto
MX2017007054A (en) Compositions and methods of using modified release solabegron for lower urinary tract symptoms.
MX2021002633A (en) Bendamustine solid dispersions and continuous infusion.
WO2014152420A3 (en) Product and method for treating diarrhea
MY185942A (en) Selected amide of y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse